跳至主要内容
临床试验/NCT07271420
NCT07271420招募中4 期

Blood Pressure Control With Thiazide Diuretics in Peritoneal Dialysis Patients

Chinese University of Hong Kong1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2020年1月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
招募中
入组人数
40
试验地点
1
主要终点
Change in systolic and diastolic blood pressure

研究概览

简要总结

To evaluate the blood pressure lowering effects of thiazide diuretics in patients on peritoneal dialysis

详细描述

This prospective, single-center treatment-withdrawal crossover study enrolled 10 patients on chronic peritoneal dialysis (PD) and uncontrolled hypertension (SBP >140 mmHg and/or DBP >90 mmHg).

Following written informed consent, participants entered the treatment arm, receiving oral hydrochlorothiazide once daily on top of their standard of treatment for 90 days. This was followed by a 14-day washout period, after which participants entered a 90-day control period.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients on chronic peritoneal dialysis, with uncontrolled hypertension (SBP >140 mmHg and/or DBP >90 mmHg)

排除标准

  • Patients with a life expectancy of less than 3 months, planned conversion to hemodialysis, or scheduled kidney transplantation within 3 months

研究组 & 干预措施

Thiazides treatment arm

Active Comparator

干预措施: Hydrochlorothiazide 25mg once per day (Drug)

结局指标

主要结局

Change in systolic and diastolic blood pressure

时间窗: 90 days

次要结局

  • Changes in body composition measured by bio impedance spectroscopy(90 days)
  • Changes in body weight(90 days)
  • Change in urinary fractional excretion of sodium(90 days)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Chan Chun Kau Gordon

Dr

Chinese University of Hong Kong

研究点 (1)

Loading locations...

相似试验

Blood Pressure Control With Thiazide Diuretics in... | 临床试验